Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia
Abstract Autologous T cells engineered to express a chimeric antigen receptor (CAR) specific for CD19 are approved for the treatment of various CD19+ hematological malignancies. While CAR T cells induce objective responses in a majority of patients, relapse frequently occurs upon loss of CD19 expres...
Main Authors: | Mayumi Sugita, Takahiro Yamazaki, Mohammad Alhomoud, Jérémie Martinet, Jean-Baptiste Latouche, Encouse Golden, Olivier Boyer, Koen Van Besien, Silvia C. Formenti, Lorenzo Galluzzi, Monica L. Guzman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-05-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05829-6 |
Similar Items
-
CAR T-cells for T-cell acute lymphoblastic leukemia
by: Marie Emilie Dourthe, et al.
Published: (2024-06-01) -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: Ugo Testa, et al.
Published: (2024-01-01) -
CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
by: Khalil Saleh, et al.
Published: (2023-10-01) -
CAR T-Cells in Acute Lymphoblastic Leukemia: Current Status and Future Prospects
by: Abdulrahman H. Almaeen, et al.
Published: (2023-10-01) -
A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
by: Pranav Puri, BA, et al.
Published: (2021-02-01)